Analysts Viewpoint Analyzing Schrodinger Inc (SDGR) After Recent Trading Activity In a filing, Schrodinger Inc revealed its President of R&D, Therapeutics Akinsanya Karen unloaded Company’s shares for reported $0.42 million
Analysts Viewpoint Examining the Potential Price Growth of Schrodinger Inc (SDGR) Schrodinger Inc’s recent filing unveils that its President of R&D, Therapeutics Akinsanya Karen unloaded Company’s shares for reported $0.42 million